MedTrace Logo

Effect of Stablor on Visceral Fat Loss in Patients With a Metabolic Syndrome

NCT01755104 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 118

Last updated 2014-03-07

No results posted yet for this study

Summary

The purpose of the study is to evaluate the impact of the intake of a dietary supplement STABLOR™ on the change of the abdominal visceral fat mass in patients with a metabolic syndrome.

Conditions

  • Metabolic Syndrome

Interventions

DIETARY_SUPPLEMENT

Stablor

DIETARY_SUPPLEMENT

Placebo

Sponsors & Collaborators

  • Laboratoires Nutrition et Cardiometabolisme

    lead INDUSTRY

Principal Investigators

  • Karine Clement, MD · Institut CardioMetabolisme et Nutrition (ICAN)

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-01-31
Primary Completion
2014-02-28
Completion
2014-02-28

Countries

  • Canada
  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01755104 on ClinicalTrials.gov